lei
md
contribut
equal
work
word
count
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
background
clinic
outcom
patient
hubei
area
differ
aim
investig
epidemiolog
clinic
characterist
patient
hunan
adjac
hubei
doublecent
observ
studi
recruit
consecut
patient
laboratori
confirm
januari
februari
two
design
hospit
hunan
provinc
china
epidemiolog
clinic
data
patient
electron
medic
record
collect
compar
mild
moder
severecrit
group
detail
clinic
outcom
follow
februari
find
patient
categor
mild
group
moder
group
severecrit
group
median
age
patient
year
male
patient
indirect
exposur
histori
proport
patient
wuhan
severecrit
group
vs
moder
group
vs
higher
mild
group
fever
cough
fatigu
common
symptom
especi
sever
critic
patient
typic
lung
imag
find
bilater
unilater
ground
glass
opac
consolid
leukopenia
lymphopenia
eosinopenia
occur
patient
respect
increas
fibrinogen
detect
patient
avail
result
patient
posit
mycoplasma
pneumonia
chlamydia
pneumonia
antibodi
test
respect
compar
mild
moder
group
severecrit
group
rel
higher
level
neutrophil
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
decemb
coronaviru
diseas
broke
wuhan
china
quickli
spread
chines
provinc
countri
around
world
februari
owe
involv
multipl
area
declar
public
health
emerg
intern
concern
januari
februari
laboratoryconfirm
clinicalconfirm
case
china
case
outsid
china
case
china
locat
wuhan
zhang
et
al
report
largest
epidemiolog
investig
case
show
crude
case
fatal
rate
hubei
provinc
time
higher
provinc
china
indic
differ
clinic
outcom
patient
hubei
provinc
featur
outcom
patient
covid
wuhan
describ
detail
sever
studi
current
limit
studi
patient
zhejiang
beij
far
hubei
howev
clinic
characterist
progress
diseas
outsid
hubei
especi
area
near
hubei
rel
higher
risk
import
patient
remot
area
still
unknown
hunan
adjac
hubei
provinc
welldevelop
transport
system
hunan
hubei
provid
high
possibl
diseas
transmiss
earli
stage
outbreak
measur
like
citi
lockdown
traffic
restrict
taken
therefor
studi
area
near
hubei
provid
inform
clinic
characterist
experi
diagnosi
treatment
referenc
area
outsid
wuhan
countri
worldwid
current
epidem
studi
aim
investig
epidem
histori
clinic
characterist
patient
hunan
china
januari
februari
consecut
patient
confirm
admit
first
hospit
changsha
loudi
central
hospit
hunan
china
recruit
first
hospit
changsha
loudi
central
hospit
two
major
tertiari
hospit
respons
treatment
patient
assign
chines
govern
diagnost
criteria
clinic
classif
confirm
case
base
guidelin
nation
health
commiss
data
collect
analysi
case
close
contact
determin
nation
health
commiss
peopl
republ
china
prc
part
continu
public
health
outbreak
investig
thu
consid
exempt
rest
state
arteri
oxygen
partial
pressurefract
inspir
oxygen
mmhg
critic
type
one
condit
follow
respiratori
failur
need
mechan
ventil
shock
organ
failur
need
intens
care
unit
icu
monitor
treatment
continu
variabl
describ
median
interquartil
rang
iqr
categor
variabl
summar
count
percentag
categor
four
clinic
type
three
group
mild
group
moder
group
severecrit
group
statist
analysi
differ
observ
among
three
group
analyz
chisquar
test
fisher
exact
test
categor
data
oneway
anova
nonparametr
kruskalw
test
quantit
data
appropri
twotail
p
thought
significantli
differ
three
group
pairwis
comparison
signific
level
adjust
use
bonferroni
method
data
analyz
spss
version
spss
inc
chicago
il
usa
kaplanmei
curv
construct
surviv
survmin
packag
r
version
http
wwwrprojectorg
patient
laboratoryconfirm
infect
includ
studi
epidemiolog
baselin
characterist
patient
detail
shown
tabl
patient
median
age
year
iqr
year
rang
year
half
patient
age
year
patient
age
year
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
higher
mild
group
similar
result
found
histori
kind
exposur
sourc
transmiss
coexist
condit
admiss
proport
patient
hypertens
severecrit
group
higher
mild
group
vs
moder
group
vs
result
also
similar
chronic
respiratori
diseas
higher
proport
patient
severecrit
group
symptom
like
fever
dyspnea
fatigu
symptom
like
nausea
vomit
common
mild
group
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
patient
receiv
imag
examin
includ
chest
radiographi
comput
tomographi
ct
admiss
typic
manifest
ct
chest
xray
plain
film
admiss
bilater
unilater
ground
glass
opac
consolid
figur
among
patient
patient
perform
ct
within
one
week
admiss
show
medium
score
lung
involv
whole
lung
field
separ
lung
field
upper
middl
lower
severecrit
group
higher
moder
group
p
laboratori
examin
data
given
tabl
admiss
patient
show
leukopenia
white
blood
cell
count
l
lymphopenia
lymphocyt
count
l
respect
neutrophil
patient
normal
rang
thrombocytopenia
platelet
count
l
observ
patient
interestingli
patient
eosinophil
count
lower
l
situat
obvious
wors
severecrit
group
whose
medium
eosinophil
count
l
compar
mild
moder
group
severecrit
group
higher
level
neutrophil
neutrophiltolymphocyt
ratio
lower
level
lymphocyt
eosinophil
platelet
p
biochemistri
test
show
patient
increas
level
ddimer
level
higher
severecrit
group
mild
group
vs
moder
group
vs
coagul
function
test
show
increas
fibrinogen
patient
avail
result
liver
function
test
severecrit
group
higher
proport
elev
aspart
aminotransferas
ast
mild
group
vs
p
obviou
abnorm
renal
function
found
patient
without
histori
kidney
diseas
patient
hyponatremia
proport
higher
severecrit
group
mild
group
vs
moreov
erythrocyt
sediment
rate
esr
highsensit
call
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
patient
receiv
antivir
therapi
tabl
patient
discharg
hospit
symptom
reliev
chest
imag
improv
fever
abat
least
three
day
two
sampl
taken
respiratori
tract
day
apart
neg
rna
februari
patient
discharg
length
hospit
rang
day
discharg
patient
use
kaplanmei
plot
analyz
length
hospit
patient
figur
show
median
length
day
iqr
patient
die
hospit
exposur
histori
wuhan
within
day
prior
onset
ill
doublecent
observ
studi
epidemiolog
clinic
characterist
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
patient
hunan
provinc
collect
analyz
hunan
adjac
hubei
provinc
provinci
capit
changsha
kilomet
away
wuhan
anoth
citi
loudi
kilomet
away
wuhan
given
migrant
data
previou
year
lockdown
wuhan
janurari
changsha
citi
high
estim
number
import
case
studi
attempt
provid
experi
diagnosi
treatment
health
worker
area
show
characterist
patient
differ
diseas
sever
categor
sever
epidem
predict
model
seem
higher
sar
fast
increas
number
patient
wuhan
middl
januari
spread
provinc
rapidli
neighbor
provinc
hunan
nearbi
locat
develop
traffic
larg
migrant
popul
studi
none
patient
histori
direct
exposur
huanan
seafood
market
patient
indirect
exposur
histori
within
day
symptom
onset
includ
wuhan
contact
peopl
came
wuhan
contact
local
diagnos
patient
studi
also
show
proport
patient
wuhan
severecrit
group
moder
group
higher
mild
group
besid
two
death
case
studi
travel
histori
wuhan
use
good
health
show
infect
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
transmiss
intens
viru
especi
first
second
gener
transmiss
may
indic
virul
viru
decreas
limit
gener
transmiss
therefor
doctor
area
outsid
wuhan
cautiou
clinic
decis
make
patient
recent
histori
exposur
wuhan
includ
wuhan
resid
recent
travel
wuhan
diseas
onset
proport
famili
cluster
infect
studi
lower
studi
besid
none
patient
medic
staff
medic
staff
infect
wuhan
februari
demograph
clinic
characterist
patient
age
year
follow
year
age
group
severecrit
group
patient
age
respect
consist
report
guan
et
al
femal
male
patient
account
half
three
group
median
time
diseas
onset
first
admiss
studi
day
similar
recent
public
data
also
show
fever
cough
fatigu
common
symptom
severecrit
group
patient
like
two
symptom
admiss
symptom
frequent
seen
severecrit
group
nausea
vomit
common
mild
group
may
indic
differ
bodi
respons
infect
patient
differ
health
state
immun
system
defens
characterist
patient
severecrit
group
least
one
underli
diseas
concert
studi
guan
et
al
base
find
suggest
clinician
pay
attent
close
observ
patient
multipl
symptom
underli
diseas
prevent
diseas
deterior
laboratori
inspect
blood
routin
test
show
patient
leukopenia
lymphopenia
respect
interestingli
eosinopenia
detect
patient
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
especi
severecrit
group
emphas
previou
studi
indic
eosinophil
could
assist
diagnosi
sever
assess
inconsist
research
elev
ddimer
observ
major
patient
studi
level
significantli
higher
severecrit
group
consist
research
guan
myocardi
damag
elev
liver
enzym
common
mainli
happen
severecrit
group
besid
obviou
disord
renal
function
electrolyt
rel
rare
patient
patient
avail
coagul
function
test
result
elev
fibrinogen
admiss
proport
severecrit
group
even
higher
observ
studi
earli
stage
sar
patient
research
also
found
increas
fibrinogen
previou
studi
shown
sarscov
protein
regul
express
fibrinogen
lung
epitheli
cell
specul
lung
inflamm
caus
secondari
system
inflamm
activ
bodi
stress
system
may
lead
increas
fibrinogen
anoth
interest
phenomenon
consider
proport
patient
posit
result
mycoplasma
pneumonia
chlamydia
pneumonia
antibodi
test
indic
mycoplasma
pneumonia
chlamydia
pneumonia
coinfect
higher
research
previou
report
indic
mycoplasma
fermentan
enhanc
cytotox
vero
cell
infect
sarscov
indic
patient
coinfect
two
type
pathogen
may
lead
sever
state
thu
clinician
need
pay
attent
screen
two
pathogen
patient
compar
patient
confirm
wuhan
studi
show
patient
hunan
rel
higher
discharg
rate
lower
mortal
studi
patient
prone
mild
moder
type
patient
discharg
end
followup
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
length
stay
hospit
rang
day
discharg
patient
patient
die
hospit
one
death
case
year
old
man
moder
group
without
underli
diseas
fever
day
admiss
treat
antivir
therapi
includ
lopinavir
ritonavir
tablet
death
case
year
old
man
severecrit
group
also
without
underli
diseas
symptom
fever
cough
dyspnea
fatigu
day
admiss
laboratori
test
detect
decreas
level
wbc
l
lymphocyt
although
lack
evidencebas
specif
antivir
drug
almost
patient
studi
receiv
antivir
therapi
lopinavir
ritonavir
tablet
recombin
human
interferon
commonli
use
treatment
besid
chloroquin
phosphat
report
appar
efficaci
accept
safeti
multicent
clinic
trial
includ
latest
edit
guidelin
china
accord
guidelin
two
patient
studi
given
chloroquin
antivir
therapi
howev
safeti
efficaci
antivir
therapi
use
patient
need
studi
studi
provid
inform
epidemiolog
clinic
profil
adjac
area
around
hubei
provinc
hope
studi
may
provid
basi
epidemiolog
relat
measur
patient
import
area
well
clinician
make
medic
decis
sever
limit
studi
firstli
due
limit
retrospect
studi
laboratori
examin
perform
accord
toth
clinic
care
need
patient
thu
patient
laboratori
exam
result
incomlpet
secondli
given
short
observ
period
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
nearli
half
patient
still
receiv
treatment
hospit
end
followup
could
decid
mortal
prognosi
whole
case
seri
moreov
difficult
distinguish
specif
efficaci
one
singl
drug
variou
treatment
appli
simultan
guidelin
diagnosi
treatment
updat
frequent
therefor
treatment
experi
studi
care
thought
treat
patient
differ
place
circumst
research
need
verifi
safeti
efficaci
doublecent
observ
studi
hospit
patient
confirm
hunan
provinc
adjac
hubei
patient
indirect
exposur
histori
proport
patient
wuhan
severecrit
group
moder
group
higher
mild
group
clinic
characterist
patient
studi
differ
patient
wuhan
dataset
use
andor
analyz
current
studi
avail
correspond
author
reason
request
author
declar
compet
interest
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
data
collect
analysi
case
close
contact
determin
nation
health
commiss
peopl
republ
china
prc
part
continu
public
health
outbreak
investig
thu
consid
exempt
institut
review
board
approv
oral
consent
obtain
patient
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
median
length
hospit
patient
day
iqr
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
valu
number
percentag
medium
iqr
unless
state
otherwis
percentag
total
owe
miss
data
